Cargando…

I-10 Pathogenesis of muscle degeneration in periodic paralyses and DMD

Detalles Bibliográficos
Autores principales:	Lehmann-Horn, F., Weber, M.A., Nagel, A., Jurkat-Rott, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Lectures by Invited Speakers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235840/

Ejemplares similares

I-7 Autoimmune Inflammatory Myopathies: Summary on Pathogenesis and Therapies
por: Dalakas, M.
Publicado: (2011)

I-13 Muscle ryanodine receptor in congenital myopathies and channelopathies
por: Treves, S., et al.
Publicado: (2011)

I-18 Chronic muscle electrical stimulation in Myotonic Dystrophy
por: Chisari, C.
Publicado: (2011)

I-17 Functional evaluation of muscle impairment in neuromuscular disorders
por: Mazzone, E.
Publicado: (2011)

I-2 Can we bypass a muscle metabolic defect?
por: Argov, Z.
Publicado: (2011)

I-8 Muscle maturation and early pathogenic findings in spinal muscular atrophy: any clues for therapy?
por: Tizzano, E.
Publicado: (2011)

Sodium channelopathies of skeletal muscle result from gain or loss of function
por: Jurkat-Rott, Karin, et al.
Publicado: (2010)

I-23 Respiratory rehabilitation in Duchenne Muscular Dystrophy
por: Fiorentino, G., et al.
Publicado: (2011)

I-12 Timothy Syndrome and Cardiomyopathy
por: Bloise, R.
Publicado: (2011)

Do Hyperpolarization-induced Proton Currents Contribute to the Pathogenesis of Hypokalemic Periodic Paralysis, a Voltage Sensor Channelopathy?
por: Jurkat-Rott, Karin, et al.
Publicado: (2007)

I-20 Wearable monitoring systems and rehabilitation
por: De Rossi, D.
Publicado: (2011)

I-11 News in non dystrophic myotonias
por: Deymeer, F.
Publicado: (2011)

I-4 Long-term follow-up effects on enzyme replacement treatment of adult form of acid maltase deficiency myopathy
por: Angelini, C., et al.
Publicado: (2011)

I-3 Treatment of CPT2 deficiency with bezafibrate
por: Laforet, P.
Publicado: (2011)

I-5 Emerging treatment strategies in mitochondrial disorders
por: Mancuso, M.
Publicado: (2011)

I-1 History of Myology in Italy and its international collections
por: Angelini, C.
Publicado: (2011)

I-15 Neuromyotonia: Potassium channelopathy or non ionic disease?
por: Serratrice, G.
Publicado: (2011)

I-9 Opportunities and challenges of pharmaceutical research and development today
por: Middleton, L.
Publicado: (2011)

I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
por: Riccio, V., et al.
Publicado: (2011)

I-6 Pharmacological strategies for Muscular Dystrophies. Review of the literature and personal data
por: Politano, L.
Publicado: (2011)

I-19 Neuromuscular electrical stimulation training in facio-scapulo-humeral muscular dystrophy
por: Sacconi, S.
Publicado: (2011)

I-22 Early indicators of respiratory impairment in muscular dystrophies: from bioengineering to rehabilitation
por: D'Angelo, M.G.
Publicado: (2011)

I-16 Crossing barriers: how medical doctors and researchers can partner with Advocacy Groups
por: Feld, L.
Publicado: (2011)

I-14 Molecular pathomechanism of DM2/PROMM: similarities and differences between DM1 and DM2
por: Meola, G.
Publicado: (2011)

Successful treatment of periodic paralysis with coenzyme Q10: two case reports
por: Da, Yuwei, et al.
Publicado: (2016)

The impact of permanent muscle weakness on quality of life in periodic paralysis: a survey of 66 patients
por: CAVEL-GREANT, DEBORAH, et al.
Publicado: (2012)

Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation
por: Breitenbach, Simon, et al.
Publicado: (2016)

State of the art in hereditary muscle channelopathies
por: Jurkat-Rott, K., et al.
Publicado: (2010)

Pathogenesis of ectodermal dysplasia
por: Thesleff, Irma
Publicado: (2012)

JIA pathogenesis - genetics
por: Thomson, Wendy
Publicado: (2014)

The pathogenesis of macrophage activation syndrome
por: De Benedetti, Fabrizio
Publicado: (2014)

Pathogenesis of chronic migraine: the role of neuromodulators
por: D'Andrea, Giovanni
Publicado: (2015)

A gating model for wildtype and R1448H Nav1.4 channels in paramyotonia
por: HOLZHERR, BORIS, et al.
Publicado: (2014)

Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients
por: Kuhn, Marius, et al.
Publicado: (2016)

Role of regulatory T cells in the pathogenesis of HIV-1 infection
por: Lévy, Yves
Publicado: (2009)

PReS13-SPK-1240: New aspects on APS pathogenesis
por: Meroni, PL
Publicado: (2013)

PReS13-SPK-1283: Pathogenesis, diagnosis and management of neuropsychiatric SLE
por: Boumpas, D
Publicado: (2013)

Domain III S4 in closed-state fast inactivation: Insights from a periodic paralysis mutation
por: Groome, James R, et al.
Publicado: (2014)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

Recent Advances in the Pathogenesis and Drug Action in Periodic Paralyses and Related Channelopathies
por: Tricarico, Domenico, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rb1a0i27v4e4d59o8u0q50vhjb